Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
23rd March 2026 Uncategorised 0
Ondine Biomedical has announced the North American phase 3 study has reached more than 93% enrolment, bringing the company closer to FDA submission.

More: Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
Source: News
